Managing Henoch-Schonlein purpura in children with fish oil and ACE inhibitor therapy

Nephrology

Volumn 9, Issue 6, 2004, Pages 381-386

  Dixit, Mehul P ^a   Dixit, Naznin M ^a   Scott, Katherine ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Alternative therapy; Hypertension; Immunomodulation; Kidney; Proteinuria; Vasculitis

Indexed keywords

AMLODIPINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FISH OIL;

ADOLESCENT; ANAPHYLACTOID PURPURA; ARTICLE; BLOOD PRESSURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; EXCRETION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; HYPERTENSION; KIDNEY BIOPSY; MALE; PRIORITY JOURNAL; PROTEINURIA;

ADOLESCENT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHILD; FEMALE; FISH OILS; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION, RENAL; KIDNEY; KIDNEY DISEASES; MALE; PROTEINURIA; PURPURA, SCHOENLEIN-HENOCH;

EID: 12244312779     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00320.x     Document Type: Article

References (28)

1. Saulsbury FT. Henoch-Schonlein purpura. Curr. Opin. Rheumatol. 2001; 13: 35-40.
2. Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F. Clinical outcome of Schonlein-Henoch purpura nephritis in children. Pediatr. Nephrol. 1999; 13: 816-23.
3. Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis. Pediatr. Nephrol. 1998; 12: 238-43.
4. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schonlein Purpura in adults: Outcome and prognostic factors. J. Am. Soc. Nephrol. 2002; 13: 1271-8.
5. Silverstein DM, Greifer I, Folkert V, Bennett B, Corey HE, Spitzer A. Sequential occurrence of IgA nephropathy and Henoch-Schonlein purpura: Support for common pathogenesis. Pediatr. Nephrol. 1994; 8: 752-3.
6. Saulsbury FT. IgA rheumatoid factor in Henoch-Schonlein purpura. J. Pediatr. 1986; 108: 71-6.
7. Wyatt RJ, Hogg RJ. Evidence-based assessment of treatment options for children with IgA nephropathies. Pediatr. Nephrol. 2001; 16: 156-67.
8. Algoet C, Proesmans W. Renal biopsy 2-9 years after Henoch Schonlein purpura. Pediatr. Nephrol. 2003; 18: 471-3.
9. Robinson DR, Xu LL, Knoell CT et al. Alleviation of autoimmune disease by omega 3 fatty acids. World Rev. Nutr. Diet. 1994; 76: 95-102.
10. Robinson DR, Xu LL, Tateno S, Guo M, Colvin RB. Suppression of autoimmune disease by dietary n-3 fatty acids. J. Lipid Res. 1993; 34: 1435-44.
11. Coppo R, Amore A, Hogg R, Emancipator S. Idiopathic nephropathy with IgA deposits. Pediatr. Nephrol. 2000; 15: 139-50.
12. Donadio JV, Bergstralh EJ, Offord KP, Spencer DC, Holley KE. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. N. Engl. J. Med. 1994; 331: 1194-9.
13. Donadio JV, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group. J. Am. Soc. Nephrol. 1999; 10: 1772-7.
14. Walton AJ, Snaith ML, Locniskar M, Cumberland AG, Morrow WJ, Isenberg DA. Dietary fish oil and the severity of symptoms in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 1991; 50: 463-6.
15. Grimminger F, Mayser P. Lipid mediators, free fatty acids and psoriasis. Prostaglandins Leukot. Essent. Fatty Acids 1995; 52: 1-15.
16. Mayser P, Grimm H, Grimminger F. n-3 fatty acids in psoriasis. Br. J. Nutr. 2002; 87 (Suppl. 1): S77-82.
17. Pestka JJ, Zhou HR, Jia Q, Timmer AM. Dietary fish oil suppresses experimental immunoglobulin a nephropathy in mice. J. Nutr. 2002; 132: 261-9.
18. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr. Clin. North Am. 1987; 34: 571-90.
19. Saulsbury FT. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine (Baltimore) 1999; 78: 395-409.
20. Mollica F, Li Volti S, Garozzo R, Russo G. Effectiveness of early prednisone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur. J. Pediatr. 1992; 151: 140-4.
21. Bergstein J, Leiser J, Andreoli SP. Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy. Clin. Nephrol. 1998; 49: 9-14.
22. Tarshish P, Bernstein J, Edelmann CM Jr. Henoch-Schonlein purpura nephritis: Course ot disease and efficacy of cyclophosphamide. Pediatr. Nephrol. 2004; 19: 51-6.
23. Mollica F, Li Volti S, Garozzo R, Russo G. Corticosteroid therapy does not prevent nephritis in Henoch-Schonlein purpura. Pediatr. Nephrol. 1994; 8: 131.
24. Huang DC, Yang YH, Lin YT, Chiang BL. Cyclosporin A therapy for steroid-dependent Henoch-Schonlein purpura. J. Microbiol. Immunol. Infect. 2003; 36: 61-4.
25. Kehn P, Fernandes G. The importance of omega-3 fatty acids in the attenuation of immune-mediated diseases. J. Clin. Immunol. 2001; 21: 99-101.
26. Wu D, Meydani SN. n-3 polyunsaturated fatty acids and immune function. Proc. Nutr. Soc. 1998; 57: 503-9.
27. Donadio JV Jr. Omega-3 polyunsaturated fatty acids: A potential new treatment of immune renal disease. Mayo Clin. Proc. 1991; 66: 1018-28.
28. Donadio JV Jr. Use of fish oil to treat patients with immunoglobulin a nephropathy. Am. J. Clin. Nutr. 2000; 71: 373S-375S.